Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of Atorvastatin on Endothelial Function, Vascular and Myocardial Redox State in High Cardiovascular Risk Patients.

Trial Profile

Effects of Atorvastatin on Endothelial Function, Vascular and Myocardial Redox State in High Cardiovascular Risk Patients.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Atherosclerosis; Cardiovascular disorders; Coronary artery disease; Heart failure; Ischaemic heart disorders
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 16 Nov 2011 Results assessing vascular redox state and nitric oxide bioavailability presented at the 84th Annual Scientific Sessions of the American Heart Association.
    • 31 Aug 2011 Results assessing the effect of treatment on vascular nitric oxide bioavailability presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
    • 31 Aug 2011 Results assessing the effects of treatment on myocardial redox parameters presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top